News
We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at ...
Hims & Hers Health (NYSE:HIMS) stock spikes, risking a short squeeze given its elevated short interest. Read more here.
If you’re experiencing increased hair fall, vitamin D deficiency hair loss could be to blame. Lacking vital nutrients like ...
Kyle Richards daughter Sophia Umansky claims she might 'be bald' after noticing hair loss linked to weight loss medication ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Hims says a good hair day can go a long way—but what constitutes "good" differs dramatically by region so it presents a state ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.
Based in Turkey, Dr. Aygin has been instrumental in changing perceptions of the quality of Turkish healthcare, especially in ...
Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...
Overall, though, we'd argue that HIMS's stock is in a great position to sell puts on. At this price, the options pay a ...
A 28-year-old man has revealed a harrowing nine-month struggle with a popular hair loss drug, describing the mostly sexual ...
Reported side effects include “erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido and testicular pain,” the FDA said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results